Description
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog consisting of 44 amino acids. It features the addition of a trans-3-hexenoic acid group to the tyrosine residue at position 1, enhancing stability over native GHRH. Each vial contains 10mg of lyophilized powder with verified purity ≥98% (HPLC).
Peptide Profile:
- Classification: GHRH analog (modified GRF 1-44)
- Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S₁
- Molecular Weight: 5135.9 g/mol
- CAS Number: 218949-48-5
Research Applications: Tesamorelin is one of the most studied GHRH analogs in endocrinology research. Published studies have investigated its role in:
- Growth hormone secretion pathways
- Pituitary function and GHRH receptor binding
- Lipid metabolism and adipose tissue biology
- IGF-1 axis modulation
- Metabolic signaling research
Key Research Context: Tesamorelin has been extensively characterized in clinical research settings, with studies examining its effects on GH pulsatility and downstream IGF-1 response. Its modified structure provides enhanced resistance to enzymatic degradation compared to endogenous GHRH.
Specifications:
- Quantity: 10mg lyophilized powder
- Purity: ≥98% (HPLC verified)
- Form: White lyophilized powder
- Solubility: Soluble in bacteriostatic water or sterile saline
- Storage: –20°C or below
- Stability: Up to 24 months when stored as directed
Handling: Supplied in stabilized lyophilized form.
This product is intended exclusively for in-vitro scientific investigation. No claims are made regarding safety, efficacy, or suitability for diagnostic, therapeutic, or dietary use.
For laboratory research use only. Not for human or veterinary consumption.
